Press Releases

News Brief

Samsung Biologics to Present at the 39th J.P. Morgan Healthcare Conference

Samsung Biologics to Present at the 39th J.P. Morgan Healthcare Conference Jan 11-14, 2021

Samsung Biologics is virtually participating in the 39th annual J.P Morgan Healthcare Conference, taking place from the 11th to Jan 14th this year. The conference aims to feature leading innovators worldwide to address arising health challenges and share ideas and solutions to reshape future wellness.  

This year will be Samsung Biologics' fifth year to present at the event's main track session. John Rim, the Company's newly appointed CEO, is scheduled to share the Company's vision, insight, and future investments for the next decade on Wednesday this week, Jan 13th. 

Samsung Biologics will also be available at the BIO One-on-One Partnering to discuss effective ways to expedite successful processes to deliver innovative solutions to the health industry. 
Samsung Biologics to Present at the 39th J.P. Morgan Healthcare Conference

Samsung Biologics is virtually participating in the 39th annual J.P Morgan Healthcare Conference, taking place from the 11th to Jan 14th this year. The conference aims to feature leading innovators worldwide to address arising health challenges and share ideas and solutions to reshape future wellness.  

This year will be Samsung Biologics' fifth year to present at the event's main track session. John Rim, the Company's newly appointed CEO, is scheduled to share the Company's vision, insight, and future investments for the next decade on Wednesday this week, Jan 13th. 

Samsung Biologics will also be available at the BIO One-on-One Partnering to discuss effective ways to expedite successful processes to deliver innovative solutions to the health industry. 

SITE MAP

close
Close

Your download is ready

Click Download.

Close

Subscribe to Our Newsletter

Please fill in your details, select one or more areas of interest, and click the subscribe button to receive our newsletter.

Subscribe to Our Newsletter
  • Interests
  • Privacy Policy to collect the email address that I have provided until I withdraw my consent. The collected information will only be used for the purpose of mailing service. If you do not wish to consent, you will not be able to receive the newsletter. Samsung Biologics respects the privacy of its subscribers.
Close

Please fill out the form
to view the full content

Please sign up to view the post..
* Required
Privacy Policy required
close

SECURITY REPORT

Your valuable comments contribute to protecting Samsung Biologic’s core technology and management information, as well as reinforcing domestic competency and economic development.

  • This page is created for reporting core technology and management information leakage.
  • The reported contents as well as the identity of the reporter are strictly secured.
THE MANUAL FOR SECURITY NOTIFICATION